FDA Approves Ultragenyx’s First Gene Therapy for Rare Metabolic Disease GSDIa
Ultragenyx Pharmaceutical has secured US Food and Drug Administration (FDA) approval for Genglycos, making it the first gene therapy authorized for glycogen storage disease type Ia (GSDIa). The treatment addresses ... Read More